ZA886251B - Biological materials,processes for producing biological materials and for using such materials in therapy - Google Patents

Biological materials,processes for producing biological materials and for using such materials in therapy

Info

Publication number
ZA886251B
ZA886251B ZA886251A ZA886251A ZA886251B ZA 886251 B ZA886251 B ZA 886251B ZA 886251 A ZA886251 A ZA 886251A ZA 886251 A ZA886251 A ZA 886251A ZA 886251 B ZA886251 B ZA 886251B
Authority
ZA
South Africa
Prior art keywords
materials
inhs
processes
biological materials
producing
Prior art date
Application number
ZA886251A
Other languages
English (en)
Inventor
Jean-Michel Dayer
Dayer Jean-Michel
Philippe Lucien Seckinger
Lucien Seckinger Philippe
Gonzalo Jose Mazzei
Jose Mazzei Gonzalo
Alan Reed Shaw
Reed Shaw Alan
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22218720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA886251(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of ZA886251B publication Critical patent/ZA886251B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
ZA886251A 1987-08-26 1988-08-23 Biological materials,processes for producing biological materials and for using such materials in therapy ZA886251B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8963287A 1987-08-26 1987-08-26

Publications (1)

Publication Number Publication Date
ZA886251B true ZA886251B (en) 1990-04-25

Family

ID=22218720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886251A ZA886251B (en) 1987-08-26 1988-08-23 Biological materials,processes for producing biological materials and for using such materials in therapy

Country Status (20)

Country Link
EP (1) EP0341273B1 (ko)
JP (2) JP3014099B2 (ko)
KR (2) KR0138919B1 (ko)
AT (1) ATE147408T1 (ko)
AU (1) AU633471B2 (ko)
BE (1) BE1002375A3 (ko)
CA (1) CA1341026C (ko)
DE (1) DE3855747T2 (ko)
DK (1) DK175837B1 (ko)
ES (3) ES2015348A6 (ko)
FR (1) FR2621821A1 (ko)
GB (1) GB2220662A (ko)
HK (1) HK1007748A1 (ko)
IL (1) IL87543A0 (ko)
IT (1) IT1226855B (ko)
NL (1) NL8820676A (ko)
NZ (1) NZ225940A (ko)
SE (1) SE8901342L (ko)
WO (1) WO1989001946A1 (ko)
ZA (1) ZA886251B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970002917B1 (ko) * 1988-05-27 1997-03-12 씨네겐 인코포레이티드 인터루킨-i 억제제
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
HUT64582A (en) * 1989-11-29 1994-01-28 Synergen Inc Method for producing recombinant human interleukin-1 inhibitor
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
AU7683391A (en) * 1990-04-27 1991-11-27 Upjohn Company, The Modified interleukin-1 inhibitors
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
HUP9900169A2 (hu) * 1995-09-13 2000-03-28 Takeda Chemical Industries, Ltd. Immunoszuppresszáns hatású kinolin- vagy kinozalinszármazékok és ezeket tartalmazó gyógyászati készítmények
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
FR2621821A1 (fr) 1989-04-21
ES2017274A6 (es) 1991-01-16
BE1002375A3 (fr) 1991-01-22
AU633471B2 (en) 1993-02-04
IT1226855B (it) 1991-02-19
ES2017275A6 (es) 1991-01-16
DE3855747D1 (de) 1997-02-20
KR890701629A (ko) 1989-12-21
DE3855747T2 (de) 1997-06-12
NL8820676A (nl) 1989-07-03
JP3014099B2 (ja) 2000-02-28
WO1989001946A1 (en) 1989-03-09
IT8821743A0 (it) 1988-08-25
KR0138654B1 (ko) 1998-04-30
JPH10327862A (ja) 1998-12-15
IL87543A0 (en) 1989-01-31
ES2015348A6 (es) 1990-08-16
KR0138919B1 (ko) 1998-04-30
DK203189A (da) 1989-04-26
ATE147408T1 (de) 1997-01-15
DK203189D0 (da) 1989-04-26
EP0341273B1 (en) 1997-01-08
DK175837B1 (da) 2005-03-21
SE8901342D0 (sv) 1989-04-13
NZ225940A (en) 1992-06-25
SE8901342L (sv) 1989-04-13
EP0341273A4 (en) 1990-09-19
EP0341273A1 (en) 1989-11-15
JP3217752B2 (ja) 2001-10-15
HK1007748A1 (en) 1999-04-23
GB8912533D0 (en) 1989-08-02
JPH02500643A (ja) 1990-03-08
CA1341026C (en) 2000-06-13
GB2220662A (en) 1990-01-17
AU2427288A (en) 1989-03-31

Similar Documents

Publication Publication Date Title
DE3587939D1 (de) Tumornekrosefaktor, Verfahren zu seiner Herstellung, denselben enthaltende Zusammensetzungen, dafür kodierende DNS und diese DNS verwendendes Testverfahren.
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
BR9408025A (pt) Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases
GB2220662A (en) Biological materials,processes for producing biological materials and for using such materials in therapy
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
ATE169337T1 (de) Rekombinante expressionsvektoren und reinigungsverfahren für dns-polymerase aus thermus thermophilus
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DE69222636D1 (de) Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen